MUFG Securities Americas’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.72M Buy
37,394
+3,064
+9% +$404K 0.24% 74
2026
Q1
$4.78M Buy
34,330
+906
+3% +$127K 0.31% 58
2025
Q4
$4.1M Sell
33,424
-36
-0.1% -$4.38K 0.26% 76
2025
Q3
$3.71M Buy
33,460
+5,891
+21% +$670K 0.24% 82
2025
Q2
$3.06M Buy
27,569
+5,509
+25% +$586K 0.26% 71
2025
Q1
$2.47M Buy
22,060
+3,663
+20% +$378K 0.29% 68
2024
Q4
$1.7M Buy
+18,397
New +$1.66M 0.22% 89

Other funds holding GILD

MUFG Securities Americas's GILD Position: Q2 2026 in Review

MUFG Securities Americas increased its Gilead Sciences (GILD) stake by 8.9% in Q2 2026, buying an estimated $404K and bringing the position to 37,394 shares worth $4.72M. The position accounts for 0.24% of the portfolio, ranked #74.

MUFG Securities Americas first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.78M in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MUFG Securities Americas held 37,394 shares of Gilead Sciences worth $4.72M as of Q2 2026.
  • MUFG Securities Americas bought 3,064 Gilead Sciences shares in Q2 2026, an estimated $404K.
  • Gilead Sciences made up 0.24% of MUFG Securities Americas's portfolio in Q2 2026, its #74 holding.
  • MUFG Securities Americas first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • MUFG Securities Americas's Gilead Sciences position peaked at $4.78M in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.